An Audience With in 2009

Filter By:

Article Type
Year

  • The Commissioner for Patents at the United States Patent and Trademark Office discusses the challenges that he faces as he takes up his new appointment.

    • Charlotte Harrison
    An Audience With

  • The President and Chief Executive Officer of the Austen BioInnovation Institute in Akron discusses the institute's multidisciplinary approach to innovation.

    An Audience With

  • Genentech's Vice President of Neuroscience discusses the company's renewed interest in the area.

    An Audience With

  • The Chairman of the UK's National Institute for Health and Clinical Excellence discusses the UK's payer environment.

    An Audience With

  • Millennium's Chief Scientific Officer discusses the company's approach to anticancer drug development.

    • Bethan Hughes
    An Audience With

  • MedImmune's Executive Vice President of R&D shares his excitement about the therapeutic potential of novel biologics.

    An Audience With

  • The former President of the Pharmaceutical Research Division of Warner-Lambert (Parke-Davis Company) discusses the effect of mega-mergers on pharmaceutical innovation.

    An Audience With

  • GSK's Head of R&D China discusses progress so far at the R&D site established in Shanghai in June 2007.

    An Audience With

  • The Chair of the EMEA's new Committee for Advanced Therapies discusses the challenges of developing such products.

    • Bethan Hughes
    An Audience With

  • Chief Scientific Officer of Pfizer Regenerative Medicine discusses Pfizer's move into stem-cell-based therapies.

    An Audience With

  • Former Centers for Medicare and Medicaid Services administrator and FDA commissioner discusses healthcare reform in the US

    An Audience With

  • Lilly's Executive Vice President of Science and Technology, discusses the company's R&D strategy.

    An Audience With